Podophyllin compound paint

Land: Bretland

Tungumál: enska

Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)

Virkt innihaldsefni:

Podophyllum resin

Fáanlegur frá:

A A H Pharmaceuticals Ltd

ATC númer:

D06BB04

INN (Alþjóðlegt nafn):

Podophyllum resin

Skammtar:

150mg/1ml

Lyfjaform:

Cutaneous paint

Stjórnsýsluleið:

Cutaneous

Tegund:

No Controlled Drug Status

Gerð lyfseðils:

Valid as a prescribable product

Vörulýsing:

BNF: 13070000

Vara einkenni

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Compound Podophyllin Paint B.P.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Podophyllum Resin B.P. 15.0% w/v
For excipients, see 6.1.
3.
PHARMACEUTICAL FORM
Medicinal Paint
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
Anogenital and plantar warts
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
PLANTAR WARTS
Adults, the elderly and children over 5 years
Apply the minimum amount 2 or 3 times a week to affected areas, cover
with
a piece of plaster and leave until the wart is soft; dead skin may be
removed at
intervals by rubbing with a pumice stone. The product should be kept
off
normal healthy skin and away from sensitive areas such as the eyes.
Children under 5 years
Not recommended.
ANOGENITAL WARTS
The product should be applied in a genitourinary clinic, or at a
general
practitioner’s surgery after screening for other sexually
transmitted diseases.
Adults and the elderly
Apply weekly to anogenital warts. Once applied the paint should be
covered
with soft paraffin and left for a maximum of 6 hours after which it
should be
washed off. During application care should be taken to avoid splashing
the
surrounding skin, which must be covered with soft paraffin as a
protection.
Children
Not recommended.
4.3.
CONTRA-INDICATIONS
Pregnancy and breastfeeding, facial warts, hypersensitivity to the
product.
4.4.
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
The paint is very irritant to the eyes and tender parts of the skin.
Avoid using
on normal skin and broken skin.
Where there is a large number of warts, only a few should be treated
at any
one time as severe toxicity caused by absorption of podophyllum has
been
reported.
4.5.
INTERACTIONS WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION
None known.
4.6.
PREGNANCY AND LACTATION
Not to be used in pregnancy or lactation.
4.7.
EFFECTS ON ABILITY TO DRIVE AND USE MACHINES
None known.
4.8.
UNDESIRABLE EFFECTS
Poisoning due to systemic absorption has been reported – where there
are a
large number of warts on